India to Uzbekistan Pharmaceutical Export (2026) — $196.6M, 316 Suppliers | TransData Nexus

India to Uzbekistan Pharmaceutical Export (2026) — $196.6M, 316 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to Uzbekistan

#	Formulation	Value	Share
1	Pharmaceutical Product:vitarich Tablet M	$24.3M	12.4%
2	Diclofenac Sodium and Paracetamol Tablet	$13.9M	7.1%
3	Paracetamol, Chlorpheniramine Maleate &	$7.8M	4.0%
4	Klozapin-clozapine 100 MG Tablets 5x10's	$5.7M	2.9%
5	Klozapin-clozapine 25 MG Tablets 5x10's	$5.2M	2.6%
6	Klorpromed 100-chlorpromazine Hcl 100mg	$4.4M	2.2%
7	Serrawin-10 Tablet (seratiopeptidase Tablets	$4.4M	2.2%
8	Fekron Cream (betamethasone Dipropionate	$3.9M	2.0%
9	Exclusive Noni Juice Concentrate 900ml	$3.8M	1.9%
10	Pharmaceutical Finished Product Digfol P	$3.6M	1.8%
11	Mgl IV Bottle 100ml Uzb Exp(w Ser)	$3.4M	1.7%
12	Pharmaceutical Goods/harmless Medicines	$3.2M	1.6%
13	Diclofenac Diethylamine, Linseed Oil, Me	$2.9M	1.5%
14	Klorpromed 50-chlorpromazine Hcl 50 MG T	$2.4M	1.2%
15	Osetron Ampoule. 8mg 4ml N5 (55410x5=277050 )	$1.8M	0.9%

India exports 20+ pharmaceutical formulations to Uzbekistan with a combined trade value of $196.6M. Key products include Diclofenac ($13.9M), Paracetamol ($7.8M), Ranitidine ($1.8M), Atorvastatin ($1.4M), Vaccine ($1.3M). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 5,814 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — India to Uzbekistan Trade Routes

1Diclofenac$13.9M

2Paracetamol$7.8M

3Ranitidine$1.8M

4Atorvastatin$1.4M

5Vaccine$1.3M

Top Indian Exporters to Uzbekistan

1Combitic Global Caplet Private Limited

$28.8M

2Saga Lifesciences Limited

$24.6M

3Intermed

$17.7M

4Mediwin Pharmaceuticals

$12.6M

5Dr.reddy's Laboratories Ltd

Port Analysis — India to Uzbekistan Pharmaceutical Shipments

Indian Export Ports

AHEMDABAD ICD1.6%

BARHI ICD0.2%

CHENNAI AIR0.6%

NHAVA SHEVA SEA (INNSA1)9.7%

DELHI AIR15.4%

Uzbekistan Import Ports

Tashkent19.1%

TASHKENT64.9%

Poti1.5%

Termez0.8%

Samarkand1.0%

Trade Statistics

Total Value$196.6M

Shipments5,814

Indian Exporters316

Uzbekistan Buyers559

Avg Shipment$34K

Products3,927

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B

Last updated: March 28, 2026

India–Uzbekistan Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The pharmaceutical trade corridor between India and Uzbekistan has experienced significant growth and development over the past decade. In 2024, India's pharmaceutical exports to Uzbekistan were valued at $108.68 million, marking a substantial increase from previous years. This surge can be attributed to India's expanding pharmaceutical manufacturing capabilities and Uzbekistan's growing demand for quality medicines. The establishment of a structured pharmaceutical and nutraceutical trade corridor in March 2026 further solidified this bilateral relationship, aiming to enhance regulatory alignment and market access for Indian manufacturers targeting the Eurasian market.

2India's Market Position

India holds a dominant position in Uzbekistan's pharmaceutical import market. In 2024, Uzbekistan's total pharmaceutical imports amounted to $843.17 million, with India accounting for approximately $569.53 million of this total. This substantial share underscores India's strategic importance as a key supplier of pharmaceutical products to Uzbekistan, catering to the country's increasing healthcare needs.

3Recent Developments

Uzbekistan Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1Registration Process

Indian pharmaceutical companies seeking to register products in Uzbekistan must adhere to the country's regulatory requirements, which include compliance with Good Manufacturing Practice (GMP) standards. The registration process involves submitting a comprehensive dossier, typically in the Common Technical Document (CTD) format, to the Ministry of Health of Uzbekistan. This dossier must demonstrate the product's quality, safety, and efficacy. The registration timeline can vary, but it generally includes an evaluation period followed by an on-site inspection to verify compliance with GMP standards. Notably, as of January 1, 2023, the registration of new medicines requires positive outcomes from clinical trials and examination of manufacturing conditions for GMP compliance.

2GMP & Facility Requirements

Uzbekistan mandates that pharmaceutical products imported into the country be manufactured in facilities that comply with GMP standards. The Ministry of Health conducts inspections to ensure that manufacturing sites meet these requirements. Compliance with GMP is essential for the registration and continued sale of pharmaceutical products in Uzbekistan. The Ministry of Health of Uzbekistan oversees the implementation of GMP regulations, ensuring that pharmaceutical products meet the necessary quality standards. (portfolio.afu.uz)

3Import Documentation

To import pharmaceutical products into Uzbekistan, Indian exporters must provide several key documents, including:

Certificate of Pharmaceutical Product (CPP): Confirms that the product is authorized for sale in the exporting country.

Certificate of Analysis (CoA): Provides detailed information on the product's composition and quality.

GMP Certificate: Demonstrates that the manufacturing facility adheres to GMP standards.

These documents are essential for customs clearance and regulatory approval in Uzbekistan. Additionally, compliance with Uzbekistan's customs procedures is required for the importation of pharmaceutical products.

EXPORT_TRENDS

TransData Nexus Research · Uzbekistan regulatory databasesMar 2026

FAQ — India to Uzbekistan Pharmaceutical Trade

What is the total value of India's pharmaceutical export to Uzbekistan?

India exported pharmaceuticals worth $196.6M to Uzbekistan across 5,814 verified shipments.

Who are the top Indian pharmaceutical exporters to Uzbekistan?

1. COMBITIC GLOBAL CAPLET PRIVATE LIMITED — $28.8M. 2. SAGA LIFESCIENCES LIMITED — $24.6M. 3. INTERMED — $17.7M. Total: 316 suppliers.

Which companies in Uzbekistan import pharmaceuticals from India?

1. DORI-DARMON, JSC — $17.7M. 2. SFS PHARM LLC — $13.9M. 3. BRITISH PHARMA LLC — $12.6M. 559 buyers total.

What pharmaceutical products does India export most to Uzbekistan?

1. Pharmaceutical Product:vitarich Tablet M ($24.3M, 12.4%); 2. Diclofenac Sodium and Paracetamol Tablet ($13.9M, 7.1%); 3. Paracetamol, Chlorpheniramine Maleate & ($7.8M, 4.0%); 4. Klozapin-clozapine 100 MG Tablets 5x10's ($5.7M, 2.9%); 5. Klozapin-clozapine 25 MG Tablets 5x10's ($5.2M, 2.6%)

Which ports handle pharmaceutical shipments from India to Uzbekistan?

Export: AHEMDABAD ICD, BARHI ICD, CHENNAI AIR, NHAVA SHEVA SEA (INNSA1), DELHI AIR. Import: Tashkent, TASHKENT, Poti, Termez, Samarkand.

Why does Uzbekistan import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $196.6M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Uzbekistan?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Uzbekistan pharmaceutical trade?

$33.8K per consignment across 5,814 shipments.

How many Indian pharmaceutical companies export to Uzbekistan?

316 Indian companies. Largest: COMBITIC GLOBAL CAPLET PRIVATE LIMITED with $28.8M.

How can I find verified Indian pharmaceutical suppliers for Uzbekistan?

TransData Nexus covers 316 active exporters with shipment history and trade values at transdatanexus.com.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Uzbekistan identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 5,814 verified shipments from 316 Indian exporters to 559 Uzbekistan buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

316 Exporters

559 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to Uzbekistan Pharmaceutical Export

Top Pharmaceutical Formulations — India to Uzbekistan

Top Pharmaceutical Products — India to Uzbekistan Trade Routes

Top Indian Exporters to Uzbekistan

Port Analysis — India to Uzbekistan Pharmaceutical Shipments

Indian Export Ports

Uzbekistan Import Ports

Trade Statistics

Other Destinations

India–Uzbekistan Pharmaceutical Trade Corridor Analysis

1Trade Corridor Evolution

2India's Market Position

3Recent Developments

Top Uzbekistan Buyers from India

Product Routes

Full Dataset Access

Uzbekistan Regulatory Landscape for Indian Pharmaceutical Exports

1Registration Process

2GMP & Facility Requirements

3Import Documentation

Product Categories & Therapeutic Trends — India to Uzbekistan

1Dominant Categories

2Emerging Opportunities

3Demand Drivers

Trade Policy & Tariff Intelligence — India and Uzbekistan

1Tariff & Duty Structure

2Trade Agreements

3IP & Patent Landscape

Supply Chain & Logistics — India to Uzbekistan Pharma Shipments

1Shipping Routes & Transit

2Port Infrastructure

3Cold Chain & Compliance

Market Opportunity Assessment — Uzbekistan for Indian Pharma

1Market Size & Growth

2Healthcare System

3Opportunity for Indian Exporters

Competitive Landscape — India vs Other Pharmaceutical Suppliers to Uzbekistan

1Competing Origins